Next-generation vascular stents
Atherosclerosis is a pre-cursor to heart disease that occurs when artery walls thicken due to a build-up of cholesterol. It can be treated by surgically inserting a stent, which prevents blood-flow constriction. Most stents require further surgery to remove them. Some biodegradable stents are already being used in clinical trials, but their degradation is non-uniform and could cause structural damage.
The research team produced stents from a magnesium, zinc and zirconium alloy, called JBDM, that biodegraded in a uniform manner and maintained their structure when tested in a rabbit for 16 weeks. The magnesium alloy will eventually dissolve completely in the physiological environment and can be metabolised and absorbed by the body.
Original publication
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.